Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCB1 | P08183 | 1/20 | 0.33 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.33 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.30 |
| ▸ | F9 | P00740 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19429038 | 0.96 | F9 (0.32) | ABCB1PDK2F9 | |
| SCHEMBL19429120 | 0.96 | PDK2 (0.33) | ABCB1PDK2PIM3 | |
| SCHEMBL21281949 | 0.96 | PDK2 (0.35) | ABCB1PDK2 | |
| SCHEMBL19429072 | 0.95 | ABCB1 (0.31) | ABCB1PDK2 | |
| SCHEMBL23515883 | 0.95 | ABCB1 (0.32) | ABCB1PDK2F9 | |
| SCHEMBL27283477 | 0.94 | PDK2 (0.34) | ABCB1PDK2PIM3F9 | |
| SCHEMBL19429326 | 0.94 | PDK2 (0.31) | PDK2PIM3F9 | |
| SCHEMBL23515801 | 0.94 | ABCB1 (0.31) | ABCB1PIM3F9 | |
| SCHEMBL16124241 | 0.93 | ABCB1 (0.34) | ABCB1PDK2F9 | |
| SCHEMBL19152857 | 0.93 | ALDH1A1 (0.34) | ABCB1PDK2F9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230009845-A1 | ORGANIC ELECTRIC ELEMENT COMPRISING A PLURALITY OF EMISSION-AUXILIARY LAYERS AND ELECTRONIC DEVICE COMPRISING IT | DUK SAN NEOLUX CO., LTD. (KR) | 2023-01-12 | — | — | US | disclosed |
| US-11205755-B2 | Compound for organic electronic element, organic electronic element using same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2021-12-21 | — | — | US | disclosed |
| US-20190296248-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
| US-20190229271-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRONIC ELEMENT | DUK SAN NEOLUX CO., LTD. (KR) | 2019-07-25 | — | — | US | disclosed |
| US-20190189927-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2019-06-20 | — | — | US | disclosed |
| WO-2018021737-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2018-02-01 | — | — | WO | disclosed |
| WO-2018012780-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRIC ELEMENT | 덕산네오룩스 주식회사 | 2018-01-18 | — | — | WO | disclosed |
| WO-2017204556-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | 덕산네오룩스 주식회사 | 2017-11-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11205755-B2 | Compound for organic electronic element, organic electronic element using same, and electronic device thereof | PIEZO1, OR51E2, ORAI2 | ABCB1 2975/4885PDK2 1746/4885PIM3 1401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.